Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals

EBioMedicine

Volumn 2, Issue 9, 2015, Pages 1160-1168

  Achkar, Jacqueline M ^a   Cortes, Laetitia ^b   Croteau, Pascal ^b   Yanofsky, Corey ^b   Mentinova, Marija ^b   Rajotte, Isabelle ^b   Schirm, Michael ^b   Zhou, Yiyong ^b   Junqueira Kipnis, Ana Paula ^c   Kasprowicz, Victoria O ^d,e,f   Larsen, Michelle ^a   Allard, René ^b   Hunter, Joanna ^b   Paramithiotis, Eustache ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Biomarker; Diagnostics; Host proteins; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; PLASMA PROTEIN;

ADULT; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERFERON GAMMA RELEASE ASSAY; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MALE; MULTIPLEX MULTIPLE REACTION MONITORING MASS SPECTROMETRY ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; THORAX RADIOGRAPHY; TISSUE REPAIR; TUBERCULIN TEST; TUBERCULOSIS; AREA UNDER THE CURVE; BLOOD; COMPLICATION; METABOLISM; MIDDLE AGED; MIXED INFECTION;

ADULT; AREA UNDER CURVE; BIOMARKERS; BLOOD PROTEINS; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TUBERCULOSIS;

EID: 84953733731     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.07.039     Document Type: Article

References (85)

1. Achkar J.M., Jenny-Avital E.R. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J. Infect. Dis. 2011, 204(Suppl. 4):S1179-S1186.
2. Achkar J.M., Jenny-Avital E., Yu X., Burger S., Leibert E., Bilder P.W., Almo S.C., Casadevall A., Laal S. Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status. Clin. Vaccine Immunol. 2010, 17:384-392.
3. Agranoff D., Fernandez-Reyes D., Papadopoulos M.C., Rojas S.A., Herbster M., Loosemore A., Tarelli E., Sheldon J., Schwenk A., Pollok R., Rayner C.F., Krishna S. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368:1012-1021.
4. American Thoracic Society Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am. J. Respir. Crit. Care Med. 2000, 161:1376-1395.
5. Anas A., Van Der Poll T., De Vos A.F. Role of CD14 in lung inflammation and infection. Crit. Care 2010, 14:209.
6. Anderson S.T., Kaforou M., Brent A.J., Wright V.J., Banwell C.M., Chagaluka G., Crampin A.C., Dockrell H.M., French N., Hamilton M.S., Hibberd M.L., Kern F., Langford P.R., Ling L., Mlotha R., Ottenhoff T.H., Pienaar S., Pillay V., Scott J.A., Twahir H., Wilkinson R.J., Coin L.J., Heyderman R.S., Levin M., Eley B. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N. Engl. J. Med. 2014, 370:1712-1723.
7. Bae Y.H., Ding Z., Das T., Wells A., Gertler F., Roy P. Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21547-21552.
8. Bantscheff M., Lemeer S., Savitski M.M., Kuster B. Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal. Bioanal. Chem. 2012, 404:939-965.
9. Berbee J.F., Coomans C.P., Westerterp M., Romijn J.A., Havekes L.M., Rensen P.C. Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix. J. Lipid Res. 2010, 51:1943-1952.
10. Berry M.P., Graham C.M., Mcnab F.W., Xu Z., Bloch S.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., Quinn C., Blankenship D., Dhawan R., Cush J.J., Mejias A., Ramilo O., Kon O.M., Pascual V., Banchereau J., Chaussabel D., O'Garra A. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
11. Blumberg H.M., Burman W.J., Chaisson R.E., Daley C.L., Etkind S.C., Friedman L.N., Fujiwara P., Grzemska M., Hopewell P.C., Iseman M.D., Jasmer R.M., Koppaka V., Menzies R.I., O'Brien R.J., Reves R.R., Reichman L.B., Simone P.M., Starke J.R., Vernon A.A. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 2003, 167:603-662.
12. Boehme C.C., Nabeta P., Hillemann D., Nicol M.P., Shenai S., Krapp F., Allen J., Tahirli R., Blakemore R., Rustomjee R., Milovic A., Jones M., O'Brien S.M., Persing D.H., Ruesch-Gerdes S., Gotuzzo E., Rodrigues C., Alland D., Perkins M.D. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 2010, 363:1005-1015.
13. Boehme C.C., Nicol M.P., Nabeta P., Michael J.S., Gotuzzo E., Tahirli R., Gler M.T., Blakemore R., Worodria W., Gray C., Huang L., Caceres T., Mehdiyev R., Raymond L., Whitelaw A., Sagadevan K., Alexander H., Albert H., Cobelens F., Cox H., Alland D., Perkins M.D. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505.
14. Bosschaerts T., Guilliams M., Noel W., Herin M., Burk R.F., Hill K.E., Brys L., Raes G., Ghassabeh G.H., De Baetselier P., Beschin A. Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J. Immunol. 2008, 180:6168-6175.
15. Burk R.F., Hill K.E. Selenoprotein P-expression, functions, and roles in mammals. Biochim. Biophys. Acta 2009, 1790:1441-1447.
16. Cdc Reported Tuberculosis in the United States, 2012 2013, US Department of Health and Human Services, CDC, Atlanta, GA.
17. Creamer J.S., Oborny N.J., Lunte S.M. Recent advances in the analysis of therapeutic proteins by capillary and microchip electrophoresis. Anal. Methods 2014, 6:5427-5449.
18. De Groote M.A., Nahid P., Jarlsberg L., Johnson J.L., Weiner M., Muzanyi G., Janjic N., Sterling D.G., Ochsner U.A. Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment. PLoS One 2013, 8:e61002.
19. Deng C., Lin M., Hu C., Li Y., Gao Y., Cheng X., Zhang F., Dong M. Exploring serological classification tree model of active pulmonary tuberculosis by magnetic beads pretreatment and MALDI-TOF MS analysis. Scand. J. Immunol. 2011, 74:397-405.
20. Druszczynska M., Wlodarczyk M., Janiszewska-Drobinska B., Kielnierowski G., Zawadzka J., Kowalewicz-Kulbat M., Fol M., Szpakowski P., Rudnicka K., Chmiela M., Rudnicka W. Monocyte signal transduction receptors in active and latent tuberculosis. Clin. Dev. Immunol. 2013, 2013:851452.
21. Du Preez I., Loots D.T. New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa. Tuberculosis (Edinb.) 2013, 93:330-337.
22. Farias-Eisner G., Su F., Robbins T., Kotlerman J., Reddy S., Farias-Eisner R. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer. Am. J. Obstet. Gynecol. 2010, 202(73):e1-e5.
23. Garcia-Gomez C., Bianchi M., De La Fuente D., Badimon L., Padro T., Corbella E., Pinto X. Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: a qualitative relationship?. World J. Orthop. 2014, 5:304-311.
24. Gonzalez-Juarrero M. Immunity to TB and targets for immunotherapy. Immunotherapy 2012, 4:187-199.
25. Haleem-Smith H., Calderon R., Song Y., Tuan R.S., Chen F.H. Cartilage oligomeric matrix protein enhances matrix assembly during chondrogenesis of human mesenchymal stem cells. J. Cell. Biochem. 2012, 113:1245-1252.
26. Hendricks P.I., Dalgleish J.K., Shelley J.T., Kirleis M.A., Mcnicholas M.T., Li L., Chen T.C., Chen C.H., Duncan J.S., Boudreau F., Noll R.J., Denton J.P., Roach T.A., Ouyang Z., Cooks R.G. Autonomous in situ analysis and real-time chemical detection using a backpack miniature mass spectrometer: concept, instrumentation development, and performance. Anal. Chem. 2014, 86:2900-2908.
27. Hochberg Y., Tamhane A.C. Multiple Comparison Procedures 2008, Wiley.
28. Hoheisel G., Zheng L., Teschler H., Striz I., Costabel U. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 1995, 108:1614-1616.
29. Hunter J.M., Paramithiotis E. Protein biomarker quantification by mass spectrometry. Expert Opin. Med. Diagn. 2010, 4:11-20.
30. Ikeda Y., Imai Y., Kumagai H., Nosaka T., Morikawa Y., Hisaoka T., Manabe I., Maemura K., Nakaoka T., Imamura T., Miyazono K., Komuro I., Nagai R., Kitamura T. Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10732-10737.
31. Ilani T., Alon A., Grossman I., Horowitz B., Kartvelishvily E., Cohen S.R., Fass D. A secreted disulfide catalyst controls extracellular matrix composition and function. Science 2013, 341:74-76.
32. Jong M.C., Hofker M.H., Havekes L.M. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 1999, 19:472-484.
33. Kaarteenaho-Wiik R., Lakari E., Soini Y., Pollanen R., Kinnula V.L., Paakko P. Tenascin expression and distribution in pleural inflammatory and fibrotic diseases. J. Histochem. Cytochem. 2000, 48:1257-1268.
34. Kaarteenaho-Wiik R., Sademies O., Paakko P., Risteli J., Soini Y. Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung. Hum. Pathol. 2007, 38:147-153.
35. Kaforou M., Wright V.J., Oni T., French N., Anderson S.T., Bangani N., Banwell C.M., Brent A.J., Crampin A.C., Dockrell H.M., Eley B., Heyderman R.S., Hibberd M.L., Kern F., Langford P.R., Ling L., Mendelson M., Ottenhoff T.H., Zgambo F., Wilkinson R.J., Coin L.J., Levin M. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med. 2013, 10:e1001538.
36. Keeping E.S. Introduction to Statistical Inference 1995, Dover Publication.
37. Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 2004, 45:1169-1196.
38. Kim M.J., Wainwright H.C., Locketz M., Bekker L.G., Walther G.B., Dittrich C., Visser A., Wang W., Hsu F.F., Wiehart U., Tsenova L., Kaplan G., Russell D.G. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2010, 2:258-274.
39. Kitchener R.L., Grunden A.M. Prolidase function in proline metabolism and its medical and biotechnological applications. J. Appl. Microbiol. 2012, 113:233-247.
40. Lawn S.D., Labeta M.O., Arias M., Acheampong J.W., Griffin G.E. Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin. Exp. Immunol. 2000, 120:483-487.
41. Le Bouc Y., Bellocq A., Philippe C., Perin L., Garabedian M., Fouqueray B., Zacharias C., Cadranel J., Baud L. Insulin-like growth factors and their binding proteins in pleural fluid. Eur. J. Endocrinol. 1997, 137:467-473.
42. Lee S., Bowrin K., Hamad A.R., Chakravarti S. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J. Biol. Chem. 2009, 284:23662-23669.
43. Lee J., Geddes K., Streutker C., Philpott D.J., Girardin S.E. Role of mouse peptidoglycan recognition protein PGLYRP2 in the innate immune response to Salmonella enterica serovar Typhimurium infection in vivo. Infect. Immun. 2012, 80:2645-2654.
44. Lesho E., Forestiero F.J., Hirata M.H., Hirata R.D., Cecon L., Melo F.F., Paik S.H., Murata Y., Ferguson E.W., Wang Z., Ooi G.T. Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis (Edinb.) 2011, 91:390-399.
45. Li X.J., Hayward C., Fong P.Y., Dominguez M., Hunsucker S.W., Lee L.W., Mclean M., Law S., Butler H., Schirm M., Gingras O., Lamontagne J., Allard R., Chelsky D., Price N.D., Lam S., Massion P.P., Pass H., Rom W.N., Vachani A., Fang K.C., Hood L., Kearney P. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci. Transl. Med. 2013, 5:207ra142.
46. Liu Q., Chen X., Hu C., Zhang R., Yue J., Wu G., Li X., Wu Y., Wen F. Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry. Lung 2010, 188:15-23.
47. Liu J., Jiang T., Wei L., Yang X., Wang C., Zhang X., Xu D., Chen Z., Yang F., Li J.C. The discovery and identification of a candidate proteomic biomarker of active tuberculosis. BMC Infect. Dis. 2013, 13:506.
48. Liu J., Jiang T., Jiang F., Xu D., Wei L., Wang C., Chen Z., Zhang X., Li J. Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis. Int. J. Clin. Exp. Med. 2015, 8:2077-2085.
49. Lu C., Wu J., Wang H., Wang S., Diao N., Wang F., Gao Y., Chen J., Shao L., Weng X., Zhang Y., Zhang W. Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One 2011, 6:e24290.
50. Maertzdorf J., Repsilber D., Parida S.K., Stanley K., Roberts T., Black G., Walzl G., Kaufmann S.H. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 2011, 12:15-22.
51. Maiga M., Agarwal N., Ammerman N.C., Gupta R., Guo H., Maiga M.C., Lun S., Bishai W.R. Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model. PLoS One 2012, 7:e30749.
52. Martinez-Bartolome S., Deutsch E.W., Binz P.A., Jones A.R., Eisenacher M., Mayer G., Campos A., Canals F., Bech-Serra J.J., Carrascal M., Gay M., Paradela A., Navajas R., Marcilla M., Hernaez M.L., Gutierrez-Blazquez M.D., Velarde L.F., Aloria K., Beaskoetxea J., Medina-Aunon J.A., Albar J.P. Guidelines for reporting quantitative mass spectrometry based experiments in proteomics. J. Proteomics 2013, 95:84-88.
53. + transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)-a novel, patentable approach to limit the emergence of XDR-TB. Recent Pat. Antiinfect. Drug Discov. 2011, 6:110-117.
54. Mazurek M., Jereb J., Vernon A., Lobue P., Goldberg S., Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm. Rep. 2010, 59:1-25.
55. Mcnicol A., Israels S.J. Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc. Hematol. Disord. Drug Targets 2008, 8:99-117.
56. Montgomery D.C. Design and Analysis of Experiments 2001, Wiley.
57. Murphy-Ullrich J.E., Lightner V.A., Aukhil I., Yan Y.Z., Erickson H.P., Hook M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J. Cell Biol. 1991, 115:1127-1136.
58. Nahid P., Bliven-Sizemore E., Jarlsberg L.G., De Groote M.A., Johnson J.L., Muzanyi G., Engle M., Weiner M., Janjic N., Sterling D.G., Ochsner U.A. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis (Edinb.) 2014, 94:187-196.
59. New York City Department of Health and Mental Hygiene 2013, Bureau of Tuberculosis Control Annual Summary, New York, available at http://www.nyc.gov/html/doh/downloads/pdf/tb/tb2013.pdf.
60. Nosov V., Su F., Amneus M., Birrer M., Robins T., Kotlerman J., Reddy S., Farias-Eisner R. Validation of serum biomarkers for detection of early-stage ovarian cancer. Am. J. Obstet. Gynecol. 2009, 200(639):e1-e5.
61. Oikonomopoulou K., Li L., Zheng Y., Simon I., Wolfert R.L., Valik D., Nekulova M., Simickova M., Frgala T., Diamandis E.P. Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. Br. J. Cancer 2008, 99:1103-1113.
62. Paakko P., Kaarteenaho-Wiik R., Pollanen R., Soini Y. Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2000, 161:967-972.
63. Pai M., Minion J., Sohn H., Zwerling A., Perkins M.D. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin. Chest Med. 2009, 30:701-716. (viii).
64. Patel V.J., Thalassinos K., Slade S.E., Connolly J.B., Crombie A., Murrell J.C., Scrivens J.H. A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J. Proteome Res. 2009, 8:3752-3759.
65. Petit V., Thiery J.P. Focal adhesions: structure and dynamics. Biol. Cell. 2000, 92:477-494.
66. Ray S., Patel S.K., Kumar V., Damahe J., Srivastava S. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteomics Clin. Appl. 2014, 8:53-72.
67. Reid M.J., Shah N.S. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect. Dis. 2009, 9:173-184.
68. Russell D.G., Vanderven B.C., Lee W., Abramovitch R.B., Kim M.J., Homolka S., Niemann S., Rohde K.H. Mycobacterium tuberculosis wears what it eats. Cell Host Microbe 2010, 8:68-76.
69. Rylance J., Pai M., Lienhardt C., Garner P. Priorities for tuberculosis research: a systematic review. Lancet Infect. Dis. 2010, 10:886-892.
70. Singh V., Jamwal S., Jain R., Verma P., Gokhale R., Rao K.V. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe 2012, 12:669-681.
71. Skidgel R.A., Erdos E.G. Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator. Int. Immunopharmacol. 2007, 7:1888-1899.
72. Song S.H., Han M., Choi Y.S., Dan K.S., Yang M.G., Song J., Park S.S., Lee J.H. Proteomic profiling of serum from patients with tuberculosis. Ann. Lab. Med. 2014, 34:345-353.
73. Steingart K.R., Ramsay A., Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev. Anti Infect. Ther. 2007, 5:327-331.
74. Storey J.D. A direct approach to falso discovery rates. J. R. Stat. Soc. Ser. B (Stat Methodol.) 2002, 64:479-498.
75. Villar-Centeno L.A., Diaz-Quijano F.A., Martinez-Vega R.A. Biochemical alterations as markers of dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 2008, 78:370-374.
76. Walzl G., Haks M.C., Joosten S.A., Kleynhans L., Ronacher K., Ottenhoff T.H. Clinical immunology and multiplex biomarkers of human tuberculosis. Cold Spring Harb. Perspect. Med. 2015, 5.
77. Wedepohl S., Beceren-Braun F., Riese S., Buscher K., Enders S., Bernhard G., Kilian K., Blanchard V., Dernedde J., Tauber R. l-Selectin-a dynamic regulator of leukocyte migration. Eur. J. Cell Biol. 2012, 91:257-264.
78. Weiner J., Parida S.K., Maertzdorf J., Black G.F., Repsilber D., Telaar A., Mohney R.P., Arndt-Sullivan C., Ganoza C.A., Fae K.C., Walzl G., Kaufmann S.H. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS One 2012, 7:e40221.
79. Wiley J.S., Shelley J.T., Cooks R.G. Handheld low-temperature plasma probe for portable "point-and-shoot" ambient ionization mass spectrometry. Anal. Chem. 2013, 85:6545-6552.
80. World Health Organization Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland http://www.who.int/tb/challenges/hiv/ICF_IPTguidelines/en/.
81. World Health Organization Global tuberculosis report 2014. Geneva, Switzerland http://www.who.int/tb/publications/global_report/en/.
82. Xu D.D., Deng D.F., Li X., Wei L.L., Li Y.Y., Yang X.Y., Yu W., Wang C., Jiang T.T., Li Z.J., Chen Z.L., Zhang X., Liu J.Y., Ping Z.P., Qiu Y.Q., Li J.C. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics 2014, 14:322-331.
83. Xu D., Li Y., Li X., Wei L.L., Pan Z., Jiang T.T., Chen Z.L., Wang C., Cao W.M., Zhang X., Ping Z.P., Liu C.M., Liu J.Y., Li Z.J., Li J.C. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics 2015, 15:58-67.
84. Yu X., Prados-Rosales R., Jenny-Avital E.R., Sosa K., Casadevall A., Achkar J. Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status. Clin. Vaccine Immunol. 2012, 19:198-208.
85. Zhang J., Wu X., Shi L., Liang Y., Xie Z., Yang Y., Li Z., Liu C., Yang F. Diagnostic serum proteomic analysis in patients with active tuberculosis. Clin. Chim. Acta 2012, 413:883-887.